Addressing antimicrobial resistance for better care in cancer patients

  15 October 2021

Infections in cancer patients are a very common complication making the routine use of antibiotics lifesaving in the treatment of these patients. As many as 1 in 5 cancer patients undergoing treatment will need antibiotics during their treatment1. Infections in cancer patients may be related to an immunosuppressed state due to alteration of the underlying immune system caused by the primary cancer, as is the case in some hematologic malignancies. However, more commonly cancer patients are at a high risk of infections due to the lowering of immune defences by different methods of treatment, in particular cytotoxic chemotherapy and hematopoietic stem-cell transplantation (HSCT).

Further reading: Revive
Author(s): Yehoda M. Martei and Shalini J. Zürn
Healthy Patients  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!